Expression and function of CD8 in a murine T cell hybridoma by unknown
EXPRESSION AND FUNCTION OF CD8 IN
A MURINE T CELL HYBRIDOMA
BY SHELDON E. RATNOFSKY, ANDREW PETERSON,*
JULIA L. GREENSTEIN, AND STEVEN J. BURAKOFF
From the Division ofPediatricOncology, Dana-Farber Cancer Institute, Departments of
Pediatrics and Pathology, HarvardMedicalSchool; and the *DepartmentofMolecular
Biology, Massachusetts General Hospital, Department of Genetics, HarvardMedicalSchool,
Boston, Massachusetts02115
In addition to the TCR, a number of other cell surface molecules play a role
in T cell activation and T cell effector function (see reference 1). Among the
various cell surface antigens involved in T cell function are the human T cell-
specific molecules CD8 (T8, Leu-2) and CD4 (T4, Leu-3). CD8 and its murine
homologue, Lyt-2, are expressed on functionally similar T cell subpopulations
(2). CD8 exists in homomultimeric configurations on the surface of human T
cells, the most common being homodimers of 67 and 76 kD (3). These two
species are thought to be conformational isomers varying only at inter- or
intrachain disulfide bonds (3, 4). Comparison of the predicted amino acid
sequence for human and murine CD8 yields an overall level of homology of 56%
(5). CD8 may be placed in the Ig supergene family, implying the potential
capacity for receptor function. At the amino acid level, it shares 30-35%
homology with a and Vu region segments and 24% homology with TCR-a and
-ß chain V segments (6).
CD8 and Lyt-2 were initially believed to be phenotypic markers for T cells
with cytotoxic or suppressor function while CD4 and its murine equivalent,
L3T4, were markers for helper T cells (2, 7, 8). The demonstration of the
existence of Lyt-2+ helper T cells specific for products of the class I region of
the MHC led to the alternate hypothesis that the Lyt-2+ phenotype correlated
with the class of MHC protein recognized by the T cell rather than with function
(8, 9). This observation was extended by studies with human lymphocytes
demonstrating CD8+ helper cells (10, 11) and CD4' cytotoxic cells (12). The
correlation between CD8 expression and class I restriction has led to the hypoth-
esis that CD8 is a receptor for nonpolymorphic determinant on the class I MHC
molecule (13), while CD4 is a receptor for nonpolymorphic determinants on the
class II MHC molecule (14, 15).
It has been proposed that one function of the CD8 and Lyt-2 molecules is to
increase the avidity with which T cells bind to target or stimulator cells. Avidity
is the strength of interaction resulting from the summation of all receptor-ligand
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pairings. The studies that led to the hypothesis that these molecules play a
supplementary or accessory role in the formation of conjugates examined the
ability of mAbs directed at either CD8 or Lyt-2 to block the function of T cell
lines (16, 17). T cells with a low-affinity TCR could be functionally inhibited by
these mAbs, suggesting that lower affinity TCR bearing T cells would place
greater reliance upon accessory molecules for cell-cell interactions.
Initially, it was assumed that inhibition of T cell function by anti-CD8 or anti-
CD4 mAbs resulted from steric inhibition of the CD8 or CD4 receptor for its
ligand. Recently, however, there has been evidence to suggest that anti-CD8 or
anti-CD4 mAbs can inhibit T cell function in the absence of a stimulator cell
expressing a putative ligand, the mAb possibly delivering an "off" or negative
signal to the T cell. For example, anti-Lyt-2 mAb inhibits lectin-dependent
cytolysis in the absence of target cells expressing MHC class I antigens (18). It
has also been demonstrated that anti-CD8 mAb inhibits anti-CD3-triggered lysis
of a class I MHC-negative target cell (19). Similarly, mAbs directed at CD4 may
also generate an off signal. Anti-L3T4 mAbs have been shown to inhibit lectin-
stimulated T cell activation in the absence of MHC class II-positive APCS (20,
21) and to inhibit lectin-activated IL-2 production by T cell hybridomas in a
culture system devoid of la' accessory cells (22). mAbs to CD4 have also been
shown to block anti-CD3 mAb-stimulated IL-2 production (23).
To address the role of CD8 in T cell activation and to define its ligand, a
murine T cell hybridoma specific for human class II antigens was generated by
immunizing C57BL/6 mice with the human EBV-transformed B cell line, JY. A
cDNA clone encoding CD8 was efficiently and functionally expressed in this T
cell hybridoma. CD8' hybridomas produced 10-fold greater IL-2 in response to
JY stimulator cells than did the CD8- parent line. This enhancement was blocked
by the addition of anti-CD8 mAb. The lack of enhancement seen when a class
I-negative, class II-positive stimulator was used and the ability to block JY
stimulation with anti-class I mAb implies that the ligand for CD8 is encoded on
the class I MHC molecules.
Materials and Methods
Construction oftheMNCT8Producer Cell Line.
￿
Amphotropic helper cell linesproducing
the MNCT8 virus were generated by transfecting the xenotropic helper cell line, MXEN
(Peterson, A., unpublished observations), using a modification of the DEAE-dextran
procedure of Seed and Aruffo (24). 48 h after transfection the supernatants from the cells
were passed through a 0.45-km filter and were used to infect the amphotropic helper
line, DAMP (Peterson, A., unpublished observations), in the presence of 10 +g/ml
polybrene. 48 h following infection selection was initiated using 500 ag/ml G418. Pooled
colonies of G418' DAMP cells were used as the MNCT8 producer line.
Expression of the CD8 Gene.
￿
BY155.16 (25) was infected with the recombinant retro-
virus MNCT8 by coculture with the MNCT8 transfected producer line. -5 X 105
bybridoma cells were added to a half-confluent 10-cm monolayer plate of MNCT8 DAMP
in the presence of 8 jug/ml polybrene. After 48 h, the cells were transferred to 24-well
plates at 10' hybridoma cells per well in 1 ml of tissue culture medium containing the
neomycin analog G418 at 2 mg/ml. Resistant cells were visible microscopically within 5 d
of transfer. All lines were then passaged in the absence of G418 without alteration in the
expression of membrane-associated CD8.
Indirect ImmunofluorescentStaining.
￿
All staining was done in V-bottomed 96-well plates
in a volume of 50 ,l of antibody. The mouse mAb OKT8, which is specific for an epitopeRATNOFSKY ET AL.
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of the CD8 molecule, was raised as an ascites and used at a concentration of 5 kg/ml.
F23.1, a mouse mAb directed at a TCR allotype, and M17/5.2, a rat mAb specific for
the murine lymphocyte function-associated antigen 1 (LFA-1)' molecule, were both used
as undiluted culture supernatants. All groups were incubated with their first antibody
(described above) on ice for 30 min. After two washes with cold PBScontaining 2% FCS,
50 ul of a 1:25 dilution of fluorescein-conjugated F(ab')2 anti-mouse or anti-rat Ig were
added for 40 min on ice. All groups were then washed three times and fixed with 2%
paraformaldehyde. Fluorescence was assessed by flow cytometry (Epics IV, Coulter
Electronics, Hialeah, FL).
IL-2 Assay.
￿
5 x 10' hybridomacells were cultured with irradiated (5,000 rad) JY cells
in a finalvolume of i ml of RPMI 1640 containing 2mM glutamine, 10% heat-inactivated
FCS, and 5 X 10-5 M 2-ME. Supernatants transferred from cells were frozen and thawed,
and assayed for IL-2 content by their ability to support the incorporation of [5H]TdR by
the IL-2-dependent cell line, CTLL20 (26). The data are converted to units of IL-2 per
milliliter by comparison to a rat Con Asupernatant. Half-maximal 5H incorporation with
the supernatant is defined as 100 U of IL-2 per milliliter.
Antibodies.
￿
Thefluorescein-conjugated F(ab')2antibodies goat anti-mouse IgG + IgM
and goat anti-rat IgG + IgM were purchased from Tago, Inc., Burlingame, CA. Leu-3a
was obtained from Becton Dickinson & Co., Mountain View, CA. OKT8C and F mAb
were a generous gift of Dr. Gideon Goldstein, Ortho Pharmaceutical, Raritan, NJ. The
OKT8-producing hybridoma was obtained through American Type Culture Collection
(ATCC), Rockville, MD, and was initially described by Hoffman et al. (27). All HLA class
I-specific hybridoma lines werepurchasedfrom ATCC.TheHLA-B7-specifichybridomas
ME1 and MB40.2 were initially describedby Ellis et al. (28) andParham (29), respectively.
The HLA-A2-specific hybridomas, MA2.1 and PA2.1, were described by McMichael et
al. (30) and Parham and Bodmer (31), respectively. The murine LFA-1-specific mAb
M17/5.2 was described by Davignon et al. (32). The HLA-DR-specific mAb TS1/16 was
generatedby Sanchez-Madrid et al. (33). The mAb for Lyt-2.2 was obtained from ATCC
and was initially described by Raulet et al. (34). The TCR-specific mAb F23.1 was
generated by Staerz et al. (35).
Results
Expression of CD8 in a Murine T Cell Hybridoma.
￿
Murine T cell hybridomas
were derived by the fusion of C57BL/6 spleen cells, from mice immunized with
thehumanEpstein-Barr virus lymphoblastoid lineJY (HLA-A2,2; -B7,7; -DR4,6),
to the HAT-sensitive thymoma BW5147. The T cell hybridoma BY155.16,
which produces IL-2 in response to the class II HLA-DR antigens on JY and
Daudi cells, was isolated from this fusion .
The retroviral expression vector MNCT8 (Fig. 1) provided a technique to
readily transfer the CD8 cDNA clone (Aruffo, A., and B. Seed, unpublished
observations) into BY155.16. The promoter used to drive the CD8 cDNA clone
is a fusion between the cytomegalovirus immediate early promoter and the tat-
responsive element of the human immunodeficiency virus. It was hoped that this
portion of the HIV genome would provide a means for upregulation of cDNAs
driven by the resulting chimeric promoter upon transfection with the tat gene.
Such an effect was not detected (Peterson, A., unpublishedobservation). MNCT8
confers resistance to G418 in a eukaryotic cell by virtue of the APH(3') II gene
neo from Tn5. This neo+ element uses the left Moloney murine leukemia virus
LTR as its site for initiation of transcription . A second vector containing the
neo+ element without CD8 was used to infect the parent line with the neo gene
alone (25). Producer cell lines were constructed by transfectiog the DAMP
'Abbreviation used in this paper.
￿
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FIGURE 1 . Structure of the
retroviral vector MNCT8.
MNCT8 has retroviral tran-
scription and integration se-
quences in the long terminal
repeats (LTR) derived from
Moloney murine leukemia vi-
rus . The retroviral encapsida-
tion signals are also derived
from Moloney virus. The neo'
element is the APH (3') II
gene from Tn5 and confers
resistance to G418 in eukar
yotic cells . The messenger RNA for the neo gene and the viral genomic RNA are produced by
transcription initiation in the left LTR and polyadenylation in the right LTR. The CD8 cDNA
(isolated from the humanT cell leukemia line HPB-ALL, Aruffo,A ., and B . Seed, unpublished data)
is expressed from a subgenomic RNA initiated at an internal promoter . The internal promoter in
this case is a fusion between the cytomegalovirus immediate early promoter and the tat-responsive
element of theHIV .
TcR
￿
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FIGURE 2 . Flow cytometric analysis of
murine TCR and CD8 expression. The
neo',CD8- cell line 16.M-9 and CD8+ cell
lines 16.78-15 and 16.78-21 were as-
sessed for TCR expression by indirect
staining with the TCR mAb F23 .1 . CD8
expression was assessed by indirect im-
munofluorescence as described in Mate-
rials and Methods.
amphotropic packaging cell line (Peterson, A., unpublished observations) with
these retroviral vectors.
Two infections of BY155.16 were carried out . Of the 48 G418-resistant cell
lines derived from these infections, all were CD8' and-50% retained the ability
to secrete IL-2 in response to stimulation with JY cells . The flow cytometry
profile of two representative CD8+ hybridomas, 16.78-15 and 16.78-21, are
presented in Fig . 2. Maximal density achieved using the MNCT8 expression
system was equivalent to that found on IL-2-dependent human peripheral blood
lymphocyte-derived T cell lines . To assess the effect of infection and selection
on theseT cell hybridomas, it wasnecessary to assess theexpression oftwo other
molecules involved in T cell function, LFA-1 (32, 33) and the antigen-specific
TCR. Infection of cells by MNCT8 did not alter either the surface density of
the antigen-specific TCR as assessed by the mAb F23 .1 (Fig . 2) or LFA-I as
assessed by an anti-LFA-1 mAb (data not shown) when compared with the neo+
infectant 16.M-9 or the parent cell line . All infectants derived from BY155.16
were negative for Lyt-2 expression as assessed by indirect immunofluorescence
(data not shown) .
CD8 Expression Enhances T Cell Hybridoma Function .
￿
CD8 function was as-
sessed by examining the ability of the CD8' T cell hybridomas to respond to
Pry'{,
a
W.yrtJY Cells (x /O-4)
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FIGURE 3. CD8 expression en-
hances T cell responsiveness. Anti-
gen-specific stimulation of the neo+,
CD8- cell line 16.M-9 (p) and CD8+
cell lines 16.T8-15 ([I), 16.T8-21 (A),
and 16.T8-25 (Q) with varying num-
bers of JY stimulator cells as indi-
cated were assessed. Responder cells
were culturedat 5 x 10'cells/ml with
varying numbersofJY stimulators as
indicated.
antigen in comparison to 16.M-9, the neon, CD8- infectant. On average, Tcell
hybridomas expressing CD8 produced 10-fold more IL-2 than the neo' cell line
when cultured with 105 irradiatedJY stimulator cells (Fig. 3). To determine the
efficiency of responsiveness of these CD8+ hybridomas, the IL-2 response to
varying numbers of stimulator cells was assessed (Fig. 3). All three CD8' cell
lines evaluated could be triggered to secrete IL-2 with 10-fold fewer stimulator
cells than the CD8- control. Thus, the expression of CD8 allowed these T cell
hybridomas to respond more efficiently to suboptimal levels ofantigen.
mAbs to CD8 Inhibit the Response of CD8 + Hybridomas.
￿
Stimulation of both
16.T8-25 and 16.M-9 by JY cells was completely inhibited by the addition to
culture ofanti-HLA-DR mAb(TS1/16), supporting the conclusion thatthe TCR
ofthese hybridomas is specific for HLA-DR antigens on JY. mAbs to the CD8
molecule were used to further assess the contribution ofCD8 to the response of
a CD8' infectant, the 16.T8-25 cell line (Table 1). OKT8 inhibited the response
of 16.T8-25 to JY by 84%, suggesting that the CD8 molecule was functionally
involved in T cell activation . This level of inhibition was detected with as little
as 60 ng/ml mAb (data not shown). Concentrations of up to 5,ug/ml of OKTS
did not inhibit the neon, CD8- cell line, 16.M-9. In addition, a nonspecific mAb
(Leu-3a) had no effect on either 16.M-9 or 16.T8-25. The OKT8C and OKT8F
mAb, specific for epitopes on the CD8 molecule distinct from that defined by
OKT8, were equally effective in inhibiting the response of 16.T8-25 (Table I).
mAb to Class I HLA Antigens Inhibits the Enhanced CD8 Response.
￿
The choice
of BY155.16, a murine T cell line specific for the class 11 HLA-DR antigens,
made it possible to assess whether HLA class I molecules bear the ligand for
CD8. The response of a CD8+ hybridoma to varying numbers ofJY stimulator
cel!s was analyzed in the presence or absence of anti-class I mAb specific for1752
TABLE I
CD8Expressing ClassH-specific T Cell Hybridomas Are Blocked by Anti-
CD8 mAb
5 X 10' T cells were cultured with 3 X 105 irradiated JY stimulator cells in a
final volume of 1 ml. All CD8-specific mAbs were used at a final dilution of 330
ng/ml. After 18-24 h, supernatants were assayed for IL-2 by the ability to
support thegrowth of the IL-2-dependent T cell line,CTLL20.
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FIGURE 4. Inhibition of CD8-mediated en-
hancementby anti-HLA classI mAb. The anti-
HLA-A2 mAbs PA2.1 and MA2.1 andtheanti-
HLA-B7 mAbs MB. 1 and ME40.2 were added
to cultures containing theCD8* cell line 16.T8-
15 (/). Control cultures consistedof 16.T8-15
with no antibody ([I) and the neo*, CD8- cell
line 16.M-9 without antibody (p). Responders
were cultured at 5 X 10'/ml and stimulated
with varyingnumbers ofJY cells.
HLA-A2 and HLA-B7, the class I products expressed on theJY stimulator cell
(Fig. 4). The addition of anti-class I mAb markedly inhibited the ability of
16.T8-15 to respond toJY. Specifically, theresponse of 16.T8-15 in thepresence
of the anti-class I mAb was reduced to that ofthe neo+, CD8- cell line, 16.M-9.
The anti-HLA class I mAb had no effect on 16.M-9 (data not shown). When
mAbs to either HLA-A2 or -B7 alone were added to culture, there was only a
partial inhibition of the response (data not shown), suggesting that the CD8
molecule can interact with either the HLA-A2 or HLA-B7 molecules. Thus, the
addition to culture of mAbs directed to the class I antigens on theJY stimulator
cells inhibited the enhanced Tcell response observed with CD8 expression.
The requirement for expression ofclass I antigens on the stimulator for CD8
function was also demonstrated genetically. The human cell line Daudi is HLA-
DR' but expresses no class I MHC antigens due to its inability to synthesize 02-
mAbadded Specificity
IL-2
16.M-9
Inhibition
16.T8-25
IL-2 Inhibition
U/ml 9o U/ml %
- 80 - 526 -
OKT8 Anti-CD8 98 0 86 84
OKT8C Anti-CD8 98 0 80 85
OKT8F Anti-CD8 74 7 80 85
Leu3a Anti-CD4 78 2 534 0
TS1/16 Anti-class II 16 80 28 95TABLE II
CD8-mediated Enhancement Requires Class IMHC Expression on
the Stimulator
RATNOFSKY ET AL.
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Discussion
5 X 10' Tcells were cultured with 3 X 10'JY or Daudistimulator cells in
a final volume of 1 ml. After 18-24 h, the culture supernatants were
assayed for IL-2 by theability to supportgrowth ofthe IL-2-dependent T
Cell line, CTLL20.
microglobulin (36). As can be seen in Table II, the CD8'' infectants 16.T8-15
and 16.T8-21 responded at best twofold better than 16.M-9 to Daudi, but they
responded up to 10-fold better than 16.M-9 to JY. These data suggest that the
enhanced response observed with the CD8+ hybridomas requires the expression
of class I MHC antigens on the stimulator cell. Thus, both mAb blocking and
stimulation with a class 1-negative cell line suggest that class I HLA molecules
encode the ligand for CD8.
We have expressed a CD8 cDNA clone in a murine T cell hybridoma that is
specific for human class II antigens. The function of CD8 was assessed by the
demonstration of the increased efficiency with which these T cell hybridomas
respond to suboptimal and optimal levels ofantigen. Furthermore, mAbs to the
CD8 molecule substantially decreased the response of these infectants. The
ability of anti-class I-specific mAbs to inhibit the CD8-mediated enhancement
supports the hypothesis that class I MHC proteins encode the physiological ligand
for the CD8 molecule.
The ability to block T cell function with mAbs to epitopes on the CD8 molecule
can result from several possible mechanisms. Inhibition may occur by the disrup-
tion of a receptor-ligand interaction that is essential to provide sufficient avidity
for the T cell to interact with its stimulator or target cell. mAbs to CD8 might
crosslink the molecule on the surface of a T cell, thereby generating an offsignal
that inhibits subsequent T cell activation. Either or both of these mechanisms of
inhibition could be operative in the experiments reported. Our data, however,
do not provide evidence for a potent off signal delivered by the OKT8 mAb.
We were unable to totally suppress the response of the CD8' T cell hybridomas
to the JY stimulator cell, which expresses class I and class II MHC antigens. The
response in the presence of OKT8 was equivalent to that of the neo+ control. In
addition, the OKT8 mAb had no demonstrable inhibitory effect on the response
of these CD8' T cells to the class I-negative cell line Daudi (data not shown).
These results are consistent with OKT8 blocking a receptor-ligand interaction,
not with induction of an off signal . In preliminary experiments, it has been
Cell line
IL-2 production
JY
(class I+,II+)
U/ml
stimulated by:
Daudi
(class I-,II+)
U/ml
16.M-9 400 105
16.T8-15 (CD8*) 2,250 150
16.T8-21 (CD8') 2,500 2501754
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possible to significantly suppress the response to Daudi cells with the mAbs
OKT8C and OKT8F (data not shown). These mAbs are to epitopes that are
distinct from that of OKT8. These observations suggest that certain anti-CD8
mAbs might function to inhibit the CD8 receptor-ligand interaction between
stimulator/target cells, but some of these mAbs might also function to transduce
an off signal from the extracellular environment. Such an interpretation would
be consistent with the studies of Hunig (18), who was able to inhibit the lectin-
dependent lysis of H-2-negative target cells with mAbs to Lyt-2, the murine CD8
equivalent.
Noting that most murine class II-specific T cells are L3T4',Lyt-2- and most
class I-specific T cells are L3T4-, Lyt-2+, Saizawa et al. (37) have hypothesized
that a physical interaction occurs between the L3T4 molecule, the murine
equivalent of CD4, and the class II-specific TCR. The model would also suggest
a similar interaction occurs between Lyt-2 and a class I-specific TCR. The thesis
states that there is an obligatory physical association between L3T4 and the
TCR, inducing a conformational change in the TCR that results in its shift to a
higher affinity state. mAbs to L3T4 inhibit by disrupting the TCR-L3T4
association, thus preventing the TCR affinity shift from occurring. Our results,
demonstrating the ability of the CD8 molecule to augment activation of a T cell
with a class II-specific TCR, wouldappear to be inconsistent with this hypothesis.
Shimonkevitz et al. (38) studied the sensitivity to inhibition by anti-Lyt-2 mAb
in a series of Kd-specific murine cytolytic T cell clones. As a target cell, they used
a cell line that expressed very low basal levels of the H-2 Kd antigen but could
be induced to express greater levels by incubation with IFN-y. T cell clones that
could lyse uninduced targets were insensitive to anti-Lyt-2 mAb inhibition. Those
that could only lyse IFN-y-induced targets were susceptible to the effect of anti-
Lyt-2 mAb. They concluded that high-avidity T cell clones, as defined by their
ability to recognize a low density of MHC on target cells, functioned independ-
ently of Lyt-2. Conversely, the low-affinity clones, those that required the greater
antigen density present on IFN-y-induced targets, relied on Lyt-2 to increase
their ability to adhere to target cells. Consistent with this conclusion, Dembic et
al. (39) transfected a Lyt-2 cDNA clone into a mouse cytotoxic T cell, and
thereby enhanced its ability to respond to antigen. Though we did not manipulate
the antigen density per cell, by coculturing the hybridomas with suboptimal
numbers of stimulator cells, we did manipulate the antigen available to these T
cell hybridomas. The ability of the CD8' hybridomas to respond to 10-fold fewer
stimulator cells would be in agreement with the interpretation of Shimonkevitz
et al. (38).
Two conclusions may be drawn from our functional studies of the CD8
molecule. First, expression of CD8 in a murine T cell hybridoma confers the
ability to respond to suboptimal amounts of antigen, and secondly, the increased
responsiveness of these HLA class II-specific T cell hybridomas was dependent
upon the expression of HLA class I products on the stimulator cells. The utility
ofthis approach in understanding the role ofT cell accessory molecules has been
recently corroborated by expressing CD4 in the same T cell hybridoma used
here (25). The data presented here further support the hypothesis that the ligand
for CD8 is on the HLA class I molecule.RATNOFSKY ET AL.
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Summary
In general, the human CD8 molecule is expressed on Tcells specific for HLA
class I molecules. Studies designed to delineate the function and to define the
ligand ofthe CD8 molecule have been complicated bythe fact that the presump-
tive ligand for CD8 is on the HLA class I molecule, the same molecule encoding
the ligand for the antigen-specific Tcell receptor. The ability to express genes
in cells other than their natural host has produced a new technology with which
to approach CD8 functional studies. The insertion ofa cDNA clone for CD8 in
a defective retroviral vector has allowed the transfer of CD8 by infection with
the resulting defective retrovirus. CD8 was then expressed in an HLA class II-
specific T cell, thus separating the ligand requirements of the TCR and CD8.
By this approach, the human CD8 molecule was expressed in a murine T cell
hybridoma specific for human class II antigens. The resulting CD8+ hybridomas
demonstrated a 10-fold increase in IL-2 production over the parent cell line
when stimulated with JY, a human B lymphoblastoid cell line expressing both
class I and II HLA antigens, demonstrating that expression of CD8 increases T
cell activation. mAbs directed against the CD8 molecule inhibited the response
of CD8' hybridomas to JY, supporting the conclusion that the CD8 molecule
was functional. The role of CD8 as a receptor for class I MHC antigens was
addressedby stimulationwith a cell lineexpressing HLA-DRantigens, butlacking
the expression ofHLA class I antigens (Daudi). Stimulation of the CD8' hybri-
domas by Daudi did not result in increased IL-2 production. The response to
Daudi was unaltered by the addition ofanti-CD8 mAb, in contrast to the ability
ofanti-CD8 mAb to blockJY stimulation. Furthermore, mAbs directed against
the class I antigens present onJY cells were able to block the enhanced response
of the CD8' hybridomas to JY. These data support the hypothesis that HLA
class I molecules are the ligands involved in the CD8-dependent enhancement
ofTcell activation.
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